Meet Our Executive Board:
Emma Jackett, Co-President
Emma joined BHIG during her freshman year, and has served as the Large-Cap Vertical Head. She is a junior concentrating in Business Economics and Biology. Her background includes scientific research work previously at Joseph DeRisi’s UCSF Biophysics and Biochemistry Lab. Emma spent this past summer at Galapagos Partners in wealth management and will be interning at Perella Weinberg Partners, a global investment bank Summer 2022.
Madeline Charles, Co-President
Madeline joined BHIG in spring of 2018 as a research analyst before becoming the vertical head of our Small-Cap pharmaceutical branch. She is a senior concentrating in Neuroscience with experience in corporate strategy at a healthcare data analytics startup. Madeline will join ClearView Healthcare Partners as a strategy analyst in 2022.
Jonathan Arditi, Chief Scientific Officer
Jonathan began his work at BHIG as a research analyst in fall of his freshman year, and by spring he was appointed Chief Science Officer and later head of BHIG's Small-Cap pharmaceuticals and startups vertical. Now a senior concentrating in Computational Biology, Jonathan is excited to leverage his BHIG roles and his passion for medical genetics to advance breakthrough biotechnology and healthcare companies. Jonathan has done award-winning traumatic brain injury research at Temple University School of Medicine, recently joined the Tapinos Lab for Molecular Neuro-Oncology at Brown University, and is guaranteed medical school enrollment through the Warren Alpert Medical School's Program in Liberal Medical Education.
Brian Showalter, Chief Investment Officer
Brad Delaney, Head of Research
Brad has been a member of BHIG since the fall of his sophomore year and a member of the executive board since the fall of his senior year. Prior to joining the board, he served as a research analyst for the Large Cap Pharma vertical. His research background includes work on pulmonary disease at Perelman School of Medicine and novel spectroscopy techniques in the Wang lab at Brown, but he currently works in the Bartnikas Lab at Brown studying novel inherited diseases of Manganese excess. Brad is currently a senior concentrator in Biochemistry who plans to research mutational trajectories of cancer through a PhD in Biomedical Sciences once he graduates.
Matthew Reisch, Senior Advisor
Matt has been a member of BHIG since the fall of his freshman year and has been a member of the executive board since the fall of his sophomore year. He has served as a research analyst, head of BHIG’s Medical Technology and Devices vertical, and most recently Co-CIO. Currently, Matt is a senior concentrating in Applied Mathematics pursuing a career in investment banking. He spent last summer as a treasury analyst at Jefferies Group and is an incoming investment banking summer analyst for Perella Weinberg Partners.
Megan Tran, Senior Advisor
Megan has been a member of BHIG since the fall of her freshman year and joined the executive team the following year. She has served as portfolio analyst, head of the Small-Cap Pharma vertical, and Co-President of the group. Megan is a senior concentrating in Biology and Economics. She has diverse interests in healthcare, finance, and technology.
Evan Mizerak, Outreach Chair
Evan has been a member of BHIG since the fall of his freshman year and has served on the executive board since the spring of his freshman year, most recently occupying the role of Co-CIO. He is a junior from central Massachusetts studying Cell Biology and Public Policy and hopes to pursue a multidisciplinary career at the intersection of those two fields.
Kat Clum, Macroeconomic Vertical Head
Kat has been a member of BHIG since the fall of her junior year and has been a member of the executive board since the fall of her senior year. She has served as a research analyst and currently heads the Macroeconomic and Policy vertical for the club. Kat is a senior concentrating in Business Economics and Psychology who is excited to work at J.P. Morgan Asset Management in New York City upon graduation. She spent her last summer working there on the client side and previously interned at Luther King Capital Management in Texas.
Meet our Analyst Team
Health Information Technology & Services
Medical Technology & Devices
Justing Song, Senior Analyst
Zeyuan Guo, Senior Analyst
Rashi Visaria, Vertical Head
Kevin Kim, Vertical Head
Shreya D'Souza, Senior Analyst
Analysts: James Park, Laney Kong, April Moon, Aayush Setty, Katie Gu, Connie Lin, Annorjan Naguleswaran, Alexander Pralea, Noa Mintz, Julia Toth, Menaka Naidu, Caroline Cheng, Olivia Pavin, Alexander Burt, Lauren Cho, Timothy Keeley
Analysts: Akshay Amesur, Nina Mehta, Nina Li, Kenny Chang, Ryan Lum, Yash Gulani, Andre Metzger, Joseph Dachinger, Elias Schwartz, Titas Grusnius, Jacob Ravich Ian Liu, Neehar Desai
Small-Cap Pharmaceuticals
Large-Cap Pharmaceuticals
Madeline Charles, Vertical Head
Juan Pablo Ramos Barros, Vertical Head
Troy Kanji, Senior Analyst
Emma Jackett, Vertical Head
Rishik Manthana, Senior Analyst
Theodore Kim, Senior Analyst
Analysts: Arjun Nanda, Chaerim Kang, Matthew Chan, Sreehari Rammohan, Ford Bennet, Musa Tahir, Alexander Kung, Youssef Gendy, Julianna Davis, Urvi Binjrajka, Elizabeth Wells, Brooke Ury, Darren Fang, Kashif Ansari, Himanssh Pettie
Science
Jonathan Arditi, Vertical Head
Brad Delaney, Vertical Head
Haobo (Jordan) Yang, Senior Analyst
Analysts: Xavi Loinaz, William MacDonald, Iris Huang, Andrew Xu, Rohan Freedman, Stephanie Carrero, William Borges, Andrew Xu, Sophia Zheng, Matthew lee
Analysts: William MacDonald, Casey Shay, Erik Stapel, Oren Lederberg, Sarah Wornow, Sophia Zheng, Elayna Tsiouplis, Stefano Chiappo, Edward Xing, Owen McWilliams, Surya Khatri, Raymond Del Vecchio, Anish Pradhan, Hannah Jeon, Caitlin McNally
Macro and policy
Brian Showalter, Vertical Head
Analysts: Ritiika Avarrsekar, Cole Exline, Alexandra Herrera, Stephanie Tu, Sashank Varanasi, Kieran Anderson, Kathleen Taylor Clum, Emily Wang, Rohit Panse